Shenzhen - Delayed Quote CNY

CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)

51.91
-0.68
(-1.29%)
At close: May 30 at 3:04:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Dr. Bing Yao GM & Executive Chairman -- -- 1977
Mr. Long Dai Secretary, CFO & Director -- -- 1992

CSPC Innovation Pharmaceutical Co., Ltd.

No. 62 Zhangju Road
Luancheng District
Shijiazhuang, 051430
China
86 311 6780 9843 https://www.xnwpharma.net
Industry: 
Packaged Foods
Full Time Employees: 
2,487

Description

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Corporate Governance

CSPC Innovation Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 23, 2025 at 10:59 AM UTC

CSPC Innovation Pharmaceutical Co., Ltd. Earnings Date

Recent Events

May 29, 2025 at 12:00 AM UTC

Ex-Dividend Date